Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Nosaki K, Yoh K, Toyozawa R, Horinouchi H, Morise M, Ohashi K, Murakami H, Satouchi M, Sakakibara-Konishi J, Yano S, Okumura F, Matsumoto S, Shimokawa M, Seto T, Goto K. Nosaki K, et al. Among authors: sakakibara konishi j. Int J Clin Oncol. 2024 May 17. doi: 10.1007/s10147-024-02543-x. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38758397
Acute onset of constrictive pericarditis due to acute myelomonocytic leukemia: A case and literature review.
Kosaka N, Uchiyama T, Onozawa M, Nagai J, Koya J, Ishizaka S, Nagai T, Ikebe Y, Kato K, Tanei ZI, Sakakibara-Konishi J, Hasegawa Y, Ohigashi H, Goto H, Hashimoto D, Ujiie H, Hirano S, Konno S, Anzai T, Taniguchi K, Tanaka S, Teshima T. Kosaka N, et al. Among authors: sakakibara konishi j. Intern Med. 2024 Apr 16. doi: 10.2169/internalmedicine.3505-24. Online ahead of print. Intern Med. 2024. PMID: 38631853 Free article.
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.
Okuma Y, Nomura S, Sakakibara-Konishi J, Tsukita Y, Murakami S, Hosomi Y, Tambo Y, Kogure Y, Yoshioka H, Tamiya M, Ninomiya K, Iwama E. Okuma Y, et al. Among authors: sakakibara konishi j. Clin Lung Cancer. 2024 Jun;25(4):389-394. doi: 10.1016/j.cllc.2024.02.002. Epub 2024 Feb 8. Clin Lung Cancer. 2024. PMID: 38413246 Clinical Trial.
Drop finger caused by lung cancer metastasis.
Sumi T, Sakakibara-Konishi J, Suzuki K, Chiba H. Sumi T, et al. Among authors: sakakibara konishi j. Respirol Case Rep. 2024 Jan 18;12(1):e01280. doi: 10.1002/rcr2.1280. eCollection 2024 Jan. Respirol Case Rep. 2024. PMID: 38239334 Free PMC article.
Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
Tsuji K, Kikuchi E, Takashima Y, Shoji T, Takahashi H, Ito S, Morinaga D, Kashima M, Maeda M, Kitai H, Kikuchi J, Sakakibara-Konishi J, Konno S. Tsuji K, et al. Among authors: sakakibara konishi j. Cell Cycle. 2023 Sep;22(17):1854-1864. doi: 10.1080/15384101.2023.2243761. Epub 2023 Aug 17. Cell Cycle. 2023. PMID: 37592765
EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment.
Shiiya A, Noguchi T, Tomaru U, Ariga S, Takashima Y, Ohhara Y, Taguchi J, Takeuchi S, Shimizu Y, Kinoshita I, Koizumi T, Matsuno Y, Shinagawa N, Sakakibara-Konishi J, Dosaka-Akita H. Shiiya A, et al. Among authors: sakakibara konishi j. Cancer Sci. 2023 Apr;114(4):1270-1283. doi: 10.1111/cas.15701. Epub 2022 Dec 26. Cancer Sci. 2023. PMID: 36529523 Free PMC article.
54 results